Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-fourmonth phase III randomized radiographic study

Author(s):
Heijde, D. van der; Tanaka, Y.; Fleischmann, R.; Keystone, E.; Kremer, J.; Zerbini, C.; Cardiel, M.H.; Cohen, S.; Nash, P.; Song, Y.W.; Tegzova, D.; Wyman, B.T.; Gruben, D.; Benda, B.; Wallenstein, G.; Krishnaswami, S.; Zwillich, S.H.; Bradley, J.D.; Connell, C.A.; ORAL Scan Investigators
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-03-31
Language
English
Is part of
Arthritis and Rheumatism (2013), Vol. 65, no. 3, p. 559-570
hdl
1887/98239
doi
10.1002/art.37816